These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1188 related articles for article (PubMed ID: 15990453)

  • 1. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy.
    Berghella AM; Totaro R; Pellegrini P; Contasta I; Russo T; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(1):29-44. PubMed ID: 15756051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
    Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
    Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis.
    Al-Shammri S; Rawoot P; Azizieh F; AbuQoora A; Hanna M; Saminathan TR; Raghupathy R
    J Neurol Sci; 2004 Jul; 222(1-2):21-7. PubMed ID: 15240191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell subsets and the regulation of Th1/Th2 responses.
    Maldonado-López R; Moser M
    Semin Immunol; 2001 Oct; 13(5):275-82. PubMed ID: 11502162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
    Kidd P
    Altern Med Rev; 2003 Aug; 8(3):223-46. PubMed ID: 12946237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.
    de Andrés C; Aristimuño C; Bartolomé M; de Las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
    J Neuroimmunol; 2009 Jul; 212(1-2):112-20. PubMed ID: 19446889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy.
    Kapsenberg ML; Hilkens CM; Wierenga EA; Kalinski P
    Clin Exp Allergy; 1999 Jun; 29 Suppl 2():33-6. PubMed ID: 10421820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
    Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells.
    Latchumanan VK; Balkhi MY; Sinha A; Singh B; Sharma P; Natarajan K
    Tuberculosis (Edinb); 2005; 85(5-6):377-83. PubMed ID: 16246624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells.
    Lee JS; Kim SG; Kim HK; Lee TH; Jeong YI; Lee CM; Yoon MS; Na YJ; Suh DS; Park NC; Choi IH; Kim GY; Choi YH; Chung HY; Park YM
    J Cell Physiol; 2007 Feb; 210(2):385-97. PubMed ID: 17058260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.